{"id":"NCT00984282","sponsor":"Bayer","briefTitle":"NexavarÂ® Versus Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer","officialTitle":"A Double-Blind Randomized Phase III Study Evaluating the Efficacy and Safety of Sorafenib Compared to Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-10-15","primaryCompletion":"2012-08-31","completion":"2017-08-30","firstPosted":"2009-09-25","resultsPosted":"2013-12-10","lastUpdate":"2018-09-13"},"enrollment":417,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Thyroid Neoplasms"],"interventions":[{"type":"DRUG","name":"Sorafenib (Nexavar, BAY43-9006)","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Sorafenib (Nexavar, BAY43-9006)","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"Trial of sorafenib versus placebo in the treatment of locally advanced or metastatic differentiated thyroid cancer refractory to radioiodine","primaryOutcome":{"measure":"Progression-free Survival (PFS) Based on Central Assessment Incl. Clinical Progression Due to Bone Irradiation","timeFrame":"Final analysis to be performed when approximately 267 progression-free survival events (centrally assessed) had occurred, study duration approximately three years","effectByArm":[{"arm":"Sorafenib (Nexavar, BAY43-9006)","deltaMin":329,"sd":null},{"arm":"Placebo","deltaMin":175,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"},{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":3},"locations":{"siteCount":81,"countries":["United States","Austria","Belgium","Bulgaria","China","Denmark","France","Germany","Italy","Japan","Netherlands","Poland","Russia","Saudi Arabia","South Korea","Spain","Sweden","United Kingdom"]},"refs":{"pmids":["26370187","24768112","21834960","31558473","31540966"],"seeAlso":["http://www.clinicaltrialsregister.eu/"]},"adverseEventsSummary":{"seriousAny":{"events":87,"n":207},"commonTop":["Hand-foot skin reaction","Diarrhea","Alopecia","Fatigue","Weight loss"]}}